Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Germany
- United Kingdom
- Portugal
- France
- Sweden
- Spain
- Netherlands
- Belgium
- Denmark
- Norway
- Italy
- Canada
- Poland
- United Arab Emirates
- Czech
- Austria
- Australia
- Singapore
- Finland
- Switzerland
- Romania
- Ireland
- Hong Kong
- China
- Japan
- Luxembourg
- Morocco
- Greece
- Brazil
- Lithuania
- Estonia
- Latvia
- Saudi Arabia
- Iceland
- Macau
- Malta
- New Zealand
- Andorra
- Bulgaria
- Cyprus
- Europe
- India
- Mexico
- Taiwan
- Worldwide
- Croatia
- Czech Republic
- Israel
- Slovakia
- South Africa
- South Korea
- Ukraine
- 43 more »
- « less
-
Program
-
Field
- Medical Sciences
- Biology
- Computer Science
- Economics
- Engineering
- Business
- Science
- Education
- Mathematics
- Chemistry
- Materials Science
- Arts and Literature
- Psychology
- Social Sciences
- Law
- Humanities
- Environment
- Linguistics
- Earth Sciences
- Sports and Recreation
- Philosophy
- Electrical Engineering
- Physics
- Design
- 14 more »
- « less
-
, E. P., BORGES, R. & MACHADO, J. D. 2021. Glucagon-like peptide-1 receptor controls exocytosis in chromaffin cells by increasing full-fusion events. Cell Reports, 36, 109609. https
-
disease-related protein aggregation. It is an interdisciplinary workplace, bringing together about 25 researchers from different backgrounds, such as bioinformatics, biophysics and cell biology. SWITCH has
-
months within the past 36 months (mobility rule). Are not employees of Charles University at the time of application deadline. Wish to conduct research at any faculty or unit of Charles University. Charles
-
to customer requests, application needs, desktops, laptops, tablets, mobile devices, printers, scanners, all in one fax/copiers, peripheral devices, etc. Equipment management including recommendations, customer
-
of HNSCCs and translating these findings to benefit patients. These are divided into below approaches. 1. HNSCC modeling a. Developed syngeneic HNSCC cell lines called the mouse oral carcinoma (MOC
-
Application Deadline 20 Apr 2026 - 17:00 (Europe/Paris) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 37.5 Offer Starting Date 1 Oct 2026 Is the job funded through the EU
-
. The objective is to develop intelligent and interoperable AI-based handover management solutions to ensure seamless mobility across multiorbit and multi-operator satellite communication systems. Phase 1 (Months 1
-
19 Mar 2026 Job Information Organisation/Company Karolinska Institutet (KI) Research Field Medical sciences » Medicine Researcher Profile First Stage Researcher (R1) Application Deadline 7 Apr 2026
-
, high-content imaging and high-throughput screening methods combined with drug design and development. Compounds will be tested in standard cell lines as well as patient-derived cells and three
-
and actuate [2], which opens new possibilities for controlling cellular function. In the recently funded RIBOTICS (RNA Origami Technology in Cell Systems) project, the lab aims to develop RNA origami